Clinical Trial

Semaglutide and Physical Activity for Obesity and Multimorbidity

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational study is to explore and describe changes in cardiometabolic health, physical activity, physical capacity, and wellbeing during interdisciplinary Semaglutide-based weight loss treatment in patients with severe obesity and multimorbidity. This study is explorative and therefore does not include hypothesis testing.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-29; most recent amendment 2024-12-09.
Status change: Recruiting → Active, Not Recruiting 2024-11-12
Status change: Not Yet Recruiting → Recruiting 2024-03-05
Trial Details
NCT Number NCT06234111
Lead Sponsor Hvidovre University Hospital
Conditions Obesity Morbid, Multimorbidity, Obesity
Enrollment 35 participants
Start Date 2024-02-20
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2024-12-12